Researchers developed two computational tools to decode how cells communicate in tissues. sCCIgen creates realistic virtual ...

The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...

AI can improve cancer outcome predictions by generating synthetic molecular data from routine pathology images, according to new research ...

Explore how AI-driven multiomics is reshaping drug discovery and personalized medicine development through innovative data ...

Adjusted EBITDA -- $1.1 million for the period, compared to an adjusted loss of $1.4 million in the same quarter last year.

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...

India’s health care system is undergoing a major shift as genomics and artificial intelligence enable predictive, preventive, ...

The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological innovation, and expanding clinical adoption. Rising global cancer ...

Cancer researchers have long treated genetic chaos and epigenetic rewiring as separate engines of disease, two parallel hallmarks that help tumors grow, spread, and resist treatment. Now a new wave of ...

The future of clinical development hinges on viewing biological systems holistically. By integrating diverse molecular data ...